NasdaqGM:GHRSPharmaceuticals
Assessing GH Research (GHRS) Valuation After New Shelf Registration And Follow On Equity Plan
Capital raising moves put GH Research in focus
GH Research (GHRS) has filed a universal shelf registration of up to US$400 million across multiple securities, alongside a US$200 million at-the-market follow-on equity program for its ordinary shares.
See our latest analysis for GH Research.
The capital raising plans come after a strong run, with the share price at US$21.88 and a 30 day share price return of 33.9%. The 1 year total shareholder return of 119.24% and 3 year total shareholder...